obesity drug news today october 2025 glp-1 GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030 obesity drug news today glp-1
Description
A plateau is something to wait out, not panic over
It contains the active ingredient semaglutide and is taken orally
Within this framework, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), originally developed for the treatment of type 2 diabetes (T2D), have recently shown cardioprotective effects beyond their role in glycaemic control
All GLP-1 RA labels mention to monitor for pancreatitis signs
However, dihydroferulic acid, a microbial metabolite of ferulic acid, markedly stimulated GLP-1 production in L-cells, highlighting a role of gut-mediated metabolism in YMs incretin effects
